Warning: Undefined array key 1 in /usr/home/goodjobsfirst/public_html/violationtrackerlive/function.php on line 727
Basic Search  |  Summaries  |  Advanced Search

929 Violation Tracker results found

Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentCurrent Parent IndustryPrimary Offense Type sort iconYearAgencyPenalty Amount
Boehringer Ingelheim Pharmaceuticals Inc.Boehringer Ingelheimpharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$95,000,000
Pfizer Inc.Pfizerpharmaceuticalsoff-label or unapproved promotion of medical products2009FDA$2,300,000,000
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2005FDA$36,000,000
InterMune Inc.Rochepharmaceuticalsoff-label or unapproved promotion of medical products2006FDA$36,900,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2013USAO$410,000,000
Amgen Inc.Amgenpharmaceuticalsoff-label or unapproved promotion of medical products2015MULTI-AG$71,000,000
AstraZenecaAstraZenecapharmaceuticalsoff-label or unapproved promotion of medical products2013KY-AG$5,500,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Boehringer Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimpharmaceuticalsoff-label or unapproved promotion of medical products2017MULTI-AG$13,500,000
Bristol-Myers SquibbBristol-Myers Squibbpharmaceuticalsoff-label or unapproved promotion of medical products2016MULTI-AG$19,500,000
Celgene Corp.Bristol-Myers Squibbpharmaceuticalsoff-label or unapproved promotion of medical products2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000
Cephalon, Inc.Teva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2008CT-AG$6,150,000
Eli LillyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2010AR-AG$18,500,000
Eli LillyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2010MS-AG$18,500,000
Eli LillyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2010LA-AG$20,000,000
Eli Lilly and Co.Eli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2009CT-AG$25,100,000
Eli Lilly and Co.Eli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2009ID-AG$13,000,000
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2008MULTI-AG$62,000,000
Endo Health SolutionEndo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsoff-label or unapproved promotion of medical products2010KY-AG$3,700,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsoff-label or unapproved promotion of medical products2009KY-AG$661,860
Inspire PharmaceuticalsMerckpharmaceuticalsoff-label or unapproved promotion of medical products2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000
InterMune Inc.Rochepharmaceuticalsoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc.Johnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2014MT-AG$5,900,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2012MULTI-AG$181,000,000
Novartis PharmaceuticalsNovartispharmaceuticalsoff-label or unapproved promotion of medical products2012TX-AG$6,638,250
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516
Par Pharmaceutical Companies Inc.Endo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000
PfizerPfizerpharmaceuticalsoff-label or unapproved promotion of medical products2014MULTI-AG$35,000,000
Purdue PharmaPurdue Pharmapharmaceuticalsoff-label or unapproved promotion of medical products2007MULTI-AG$19,500,000
Warner-LambertPfizerpharmaceuticalsoff-label or unapproved promotion of medical products2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000
Wyeth Pharmaceuticals, Inc.Pfizerpharmaceuticalsoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000
E.R. Squibb & Sons LLCBristol-Myers SquibbpharmaceuticalsPCB violation2009EPA$8,125
Pfizer PharmaceuticalsPfizerpharmaceuticalsPCB violation2010EPA$24,650
Celgene CorporationBristol-Myers SquibbpharmaceuticalsPCB violation2013EPA$6,035
EMD Millipore CorporationMerck KGaA (EMD)pharmaceuticalspesticide violation2013EPA$2,681,500
Advanced Sterilization ProductsJohnson & Johnsonpharmaceuticalspesticide violation2012CA-DPR$25,616
Pfizer Inc.Pfizerpharmaceuticalspesticide violation2012CA-DPR$6,720
Schering-Plough Healthcare Products Inc.Merckpharmaceuticalspesticide violation2011CA-DPR$28,400
Abbott Laboratories DiagnosticsAbbott Laboratoriespharmaceuticalspesticide violation2007CA-DPR$9,476
Hoechst AGSanofipharmaceuticalsprice-fixing or anti-competitive practices2003DOJ_ANTITRUST$12,000,000
Merck KgaAMerck KGaA (EMD)pharmaceuticalsprice-fixing or anti-competitive practices2000DOJ_ANTITRUST$14,000,000
Abbott LaboratoriesAbbViepharmaceuticalsprice-fixing or anti-competitive practices2005MULTI-AG$15,350,000
Abbott LaboratoriesAbbViepharmaceuticalsprice-fixing or anti-competitive practices2010MULTI-AG$22,500,000
Alpharma, Inc.Pfizerpharmaceuticalsprice-fixing or anti-competitive practices2004MULTI-AG$750,000
Amphastar Pharmaceuticals, Inc.Amphastar Pharmaceuticalspharmaceuticalsprice-fixing or anti-competitive practices2015MA-AG$325,000
Aventis Pharmaceuticals, Inc.Sanofipharmaceuticalsprice-fixing or anti-competitive practices2012MULTI-AG$1,650,000
Barr PharmaceuticalsTeva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2008MULTI-AG$5,900,000
Bausch & LombBausch Healthpharmaceuticalsprice-fixing or anti-competitive practices2001MULTI-AG$17,500,000
Bristol-Myers SquibbBristol-Myers Squibbpharmaceuticalsprice-fixing or anti-competitive practices2003MULTI-AG$55,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibbpharmaceuticalsprice-fixing or anti-competitive practices2008MULTI-AG$1,100,000
CIBA VisionNovartispharmaceuticalsprice-fixing or anti-competitive practices2000MULTI-AG$5,000,000
Daiichi PharmaceuticalDaiichi Sankyopharmaceuticalsprice-fixing or anti-competitive practices2000MULTI-AG$4,340,100
Daiichi PharmaceuticalDaiichi Sankyopharmaceuticalsprice-fixing or anti-competitive practices2000CA-AG$1,446,700
Daiichi PharmaceuticalDaiichi Sankyopharmaceuticalsprice-fixing or anti-competitive practices2002MA-AG$111,167
EisaiEisaipharmaceuticalsprice-fixing or anti-competitive practices2000MULTI-AG$7,634,700
Eisai Co.Eisaipharmaceuticalsprice-fixing or anti-competitive practices2000CA-AG$2,544,900
Eisai Co.Eisaipharmaceuticalsprice-fixing or anti-competitive practices2002MA-AG$111,167
Endo International plcEndo Internationalpharmaceuticalsprice-fixing or anti-competitive practices2019MULTI-AG$2,300,000
Geneva PharmaceuticalsNovartispharmaceuticalsprice-fixing or anti-competitive practices2005MULTI-AG$15,350,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2006MULTI-AG$14,000,000
GlaxoSmithKlineGlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2006MULTI-AG$3,500,000
Hoffman-LaRocheRochepharmaceuticalsprice-fixing or anti-competitive practices2000MULTI-AG$142,494,000
Hoffman-LaRocheRochepharmaceuticalsprice-fixing or anti-competitive practices2000CA-AG$47,498,000
Hoffman-LaRocheRochepharmaceuticalsprice-fixing or anti-competitive practices2002MA-AG$111,167
Johnson & Johnson Vision Care, Inc.Johnson & Johnsonpharmaceuticalsprice-fixing or anti-competitive practices2001MULTI-AG$60,000,000
Merck KGaAMerck KGaA (EMD)pharmaceuticalsprice-fixing or anti-competitive practices2009MULTI-AG$2,275,454
Mylan Laboratories et al.Viatrispharmaceuticalsprice-fixing or anti-competitive practices2000MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000
Perrigo CompanyPerrigopharmaceuticalsprice-fixing or anti-competitive practices2004MULTI-AG$750,000
Ranbaxy Pharmaceuticals, Inc.Sun Pharmaceuticalspharmaceuticalsprice-fixing or anti-competitive practices2014NY-AG$150,000
SmithKline Beecham Corp.GlaxoSmithKlinepharmaceuticalsprice-fixing or anti-competitive practices2005MULTI-AG$10,000,000
Takeda ChemicalTakeda Pharmaceuticalpharmaceuticalsprice-fixing or anti-competitive practices2000MULTI-AG$17,551,650
Takeda ChemicalTakeda Pharmaceuticalpharmaceuticalsprice-fixing or anti-competitive practices2000CA-AG$5,850,550
Takeda ChemicalTakeda Pharmaceuticalpharmaceuticalsprice-fixing or anti-competitive practices2002MA-AG$111,167
Teva Pharmaceuticals USA, Inc.Teva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2014NY-AG$150,000
UCB Pharma, Inc.UCBpharmaceuticalsprice-fixing or anti-competitive practices2009MULTI-AG$2,275,454
Warner Chilcott HoldingsAbbViepharmaceuticalsprice-fixing or anti-competitive practices2007MULTI-AG$5,500,000
Sandoz Inc.Sandoz Grouppharmaceuticalsprice-fixing or anti-competitive practices2020DOJ_ANTITRUST$195,000,000
Apotex Corp.Apotex Corp.pharmaceuticalsprice-fixing or anti-competitive practices2020DOJ_ANTITRUST$24,100,000
Abbott LaboratoriesAbbViepharmaceuticalsprice-fixing or anti-competitive practices2009private lawsuit-federal$10,000,000
Abbott LaboratoriesAbbViepharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$9,615,384
Actavis Elizabeth LLCTeva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2022private lawsuit-federal$1,100,000
Actavis Elizabeth LLCTeva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2020private lawsuit-federal$19,900,000
Actavis Mid-Atlantic LLCTeva Pharmaceutical Industriespharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$118,614,000
AllerganAbbViepharmaceuticalsprice-fixing or anti-competitive practices2019private lawsuit-federal$934,903
AllerganAbbViepharmaceuticalsprice-fixing or anti-competitive practices2019private lawsuit-federal$1,003,634
AllerganAbbViepharmaceuticalsprice-fixing or anti-competitive practices2019private lawsuit-federal$806,991
AllerganAbbViepharmaceuticalsprice-fixing or anti-competitive practices2017private lawsuit-federal$15,000,000
Allergan Inc.AbbViepharmaceuticalsprice-fixing or anti-competitive practices2018private lawsuit-federal$3,000,000
Allergan, Inc.AbbViepharmaceuticalsprice-fixing or anti-competitive practices2018private lawsuit-federal$13,450,000
American BioScience Inc.Bristol-Myers Squibbpharmaceuticalsprice-fixing or anti-competitive practices2003private lawsuit-federal$815,000
Amgen Inc.Amgenpharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$9,615,384
Amneal Pharmaceuticals LLCAmneal Pharmaceuticalspharmaceuticalsprice-fixing or anti-competitive practices2019private lawsuit-federal$400,000
Astellas Pharma US, Inc.Astellas Pharmapharmaceuticalsprice-fixing or anti-competitive practices2016private lawsuit-federal$13,250,000
AstraZenecaAstraZenecapharmaceuticalsprice-fixing or anti-competitive practices2007private lawsuit-federal$24,000,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsprice-fixing or anti-competitive practices2013private lawsuit-federal$11,000,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsprice-fixing or anti-competitive practices2012private lawsuit-federal$20,000,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsprice-fixing or anti-competitive practices2011private lawsuit-federal$13,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.